Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MINISO Group Holding (MSOGF) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for MINISO Group Holding (MSOGF) over the last 7 years, with Q3 2025 value amounting to $435.3 million.

  • MINISO Group Holding's Cash & Equivalents rose 7801.14% to $435.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $435.3 million, marking a year-over-year increase of 7801.14%. This contributed to the annual value of $866.9 million for FY2024, which is 270.19% down from last year.
  • As of Q3 2025, MINISO Group Holding's Cash & Equivalents stood at $435.3 million, which was up 7801.14% from $874.9 million recorded in Q2 2025.
  • MINISO Group Holding's Cash & Equivalents' 5-year high stood at $1.1 billion during Q1 2021, with a 5-year trough of $244.5 million in Q3 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $874.9 million (2025), whereas its average is $826.9 million.
  • As far as peak fluctuations go, MINISO Group Holding's Cash & Equivalents skyrocketed by 16017.22% in 2021, and later crashed by 7065.29% in 2024.
  • Over the past 5 years, MINISO Group Holding's Cash & Equivalents (Quarter) stood at $808.4 million in 2021, then dropped by 6.97% to $752.0 million in 2022, then grew by 20.16% to $903.6 million in 2023, then dropped by 2.5% to $881.0 million in 2024, then crashed by 50.59% to $435.3 million in 2025.
  • Its Cash & Equivalents stands at $435.3 million for Q3 2025, versus $874.9 million for Q2 2025 and $942.5 million for Q1 2025.